We are a young, vibrant section dedicated to adding value to Section members interested in Innovation across the cardiovascular spectrum. Our section is member-driven and focused on all aspects of ...
Patients with atrial fibrillation (AFib) who drank an average of one cup of coffee a day following successful cardioversion had fewer recurrences of AFib or atrial flutter compared with those who ...
In this week’s View, Dr. Eagle highlights several important studies presented at the recent American Heart Association Scientific Sessions. The OCEAN Trial on antithrombotic and stroke prevention in ...
Patients with obstructive hypertrophic cardiomyopathy (oHCM) treated with aficamten saw superior benefits in heart failure symptoms, exercise capacity, left ventricular outflow tract (LVOT) gradient ...
Four major studies presented at AHA 2025 are reshaping strategies for managing atrial fibrillation (AFib) in complex clinical scenarios. OCEAN addresses whether ongoing anticoagulation is necessary ...
This episode is part of ACC’s ongoing initiative to advance heart failure (HF) care through team-based collaboration and patient-centered decision-making. Drs. Marty Tam, Lindsey Aurora, Leslie Davis, ...
Learn more about the advertising opportunities with Cardiology magazine, ACC's member magazine.
The Centers for Medicare and Medicaid Services (CMS) has issued the 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule. CMS has ...
In this episode, Keith C. Ferdinand, MD, FACC, discusses why low blood pressure (BP) should not delay heart failure (HF) treatment.
Fewer than half of young adults with severely high low-density lipoprotein (LDL-C), or “bad” cholesterol, levels start taking a statin within five years of first high LDL-C measurement, according to a ...
In this week’s View, Dr. Eagle highlights several trials recently presented at the TCT Conference in San Francisco. The SELUTION DeNovo trial found that use of the sirolimus-eluting balloons with ...
This page features ACC's full coverage of the latest science from American Heart Association's (AHA) Scientific Sessions 2025, taking place Nov. 7–10 in New Orleans, LA.